DENDREON CORP
S-1/A, EX-27.1, 2000-06-15
PHARMACEUTICAL PREPARATIONS
Previous: DENDREON CORP, S-1/A, EX-23.1, 2000-06-15
Next: DENDREON CORP, S-1/A, EX-27.2, 2000-06-15



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS RESTATED FINANCIAL DATA SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION
EXTRACTED FROM FORM S-1 REGISTRATION STATEMENT AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<RESTATED>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                           8,495
<SECURITIES>                                     5,770
<RECEIVABLES>                                      838
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                16,375
<PP&E>                                           3,954
<DEPRECIATION>                                   2,398
<TOTAL-ASSETS>                                  18,965
<CURRENT-LIABILITIES>                            6,355
<BONDS>                                              0
                                0
                                         13
<COMMON>                                             1
<OTHER-SE>                                       6,776
<TOTAL-LIABILITY-AND-EQUITY>                    18,965
<SALES>                                              0
<TOTAL-REVENUES>                                 1,181
<CGS>                                                0
<TOTAL-COSTS>                                    4,905
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 156
<INCOME-PRETAX>                                (3,662)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (3,662)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (3,662)
<EPS-BASIC>                                     (6.10)
<EPS-DILUTED>                                   (6.10)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission